REAL-WORLD UTILIZATION AND COSTS OF EXTENDED HALF-LIFE FACTOR PRODUCTS IN PEDIATRIC HEMOPHILIA B PATIENTS ON PROPHYLAXIS THERAPY

被引：0
|
作者：
Yang, Kun [1 ]
Buckley, Brieana [1 ]
Mathison, Brent [1 ]
机构：
[1] Bioverativ, Waltham, MA USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2018年 / 93卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E74 / E74
页数：1
相关论文
共 50 条
  • [1] Real-World Analysis of Factor Utilization and Costs in Hemophilia B Patients Using Standard and Extended Half-Life Recombinant Factor IX Products
    Fogarty, P.
    Alvir, J.
    Chhabra, A.
    Mcdonald, M.
    Spurden, D.
    Tortella, B.
    Pleil, A.
    [J]. HAEMOPHILIA, 2017, 23 : 14 - 15
  • [2] REAL-WORLD HEALTH CARE UTILIZATION COSTS IN HEMOPHILIA B PATIENTS USING STANDARD AND EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCTS
    Chhabra, A.
    Alvir, J.
    Tortella, B. J.
    Fogarty, P. F.
    Spurden, D.
    McDonald, M.
    Pleil, A.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A222 - A222
  • [3] Real World Analysis of Coagulation Factor IX Utilization and Costs in Hemophilia B Patients Switching From Standard Half-Life To Extended Half-Life Products
    Tortella, B. J.
    Fogarty, P. F.
    Alvir, J.
    Mcdonald, M.
    Spurden, D.
    Pleil, A. M.
    [J]. HAEMOPHILIA, 2017, 23 : 41 - 42
  • [4] Real-World Expenditures Associated with Treatment of Hemophilia a and B Patients with Standard and Extended Half-Life Factor Replacement Products in the US
    Chhabra, Amit
    Alvir, Jose
    Spurden, Dean
    Fogarty, Patrick F.
    Tortella, Bartholomew
    McDonald, Margaret
    Pleil, Andreas M.
    [J]. BLOOD, 2017, 130
  • [5] Real World Data Analysis of Coagulation Factor IX Costs in Specific Patients with Hemophilia B Switching from Standard Half-Life to Extended Half-Life Products
    Tortella, Bartholomew J.
    Fogarty, Patrick F.
    Alvir, Jose
    McDonald, Margaret
    Spurden, Dean
    Pleil, Andreas M.
    [J]. BLOOD, 2016, 128 (22)
  • [6] FACTOR DISPENSATION AND EXPENDITURES IN HEMOPHILIA B PATIENTS SWITCHING FROM STANDARD HALF-LIFE TO EXTENDED HALF-LIFE RECOMBINANT FACTOR IX REPLACEMENT PRODUCTS: REAL-WORLD ANALYSIS IN JAPAN
    Karumori, T.
    Chhabra, A.
    Alvir, J.
    Fogarty, P. F.
    Spurden, D.
    Tortella, B. J.
    Rubinstein, E.
    Pleil, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S111 - S111
  • [7] Real-World Analysis of Dispensed IUs of Coagulation Factor IX and Resultant Expenditures in Hemophilia B Patients Receiving Standard Half-Life Versus Extended Half-Life Products and Those Switching from Standard Half-Life to Extended Half-Life Products
    Tortella, Bartholomew J.
    Alvir, Jose
    McDonald, Margaret
    Spurden, Dean
    Fogarty, Patrick F.
    Chhabra, Amit
    Pleil, Andreas M.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 643 - 653
  • [8] Comparison of standard half-life to extended half-life fix products: Real-world analysis or recent factor IUS dispensed and expenditure in on-demand hemophilia B patients
    Tortella, B. J.
    Chhabra, A.
    Alvir, J.
    Fogarty, P. F.
    McDonald, M.
    Pleil, A. M.
    Spurden, D.
    [J]. HAEMOPHILIA, 2018, 24 : 57 - 57
  • [9] Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B
    Chhabra, Amit
    Spurden, Dean
    Fogarty, Patrick F.
    Tortella, Bartholomew J.
    Rubinstein, Emily
    Harris, Simon
    Pleil, Andreas M.
    Mellor, Jennifer
    de Courcy, Jonathan
    Alvir, Jose
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (03) : 186 - 192
  • [10] REAL WORLD FACTOR DISPENSATION AND EXPENDITURES IN US PATIENTS WITH HEMOPHILIA B: STANDARD HALF-LIFE VS. EXTENDED HALF-LIFE FACTOR IX REPLACEMENT PRODUCTS
    Chhabra, A.
    Spurden, D.
    Tortella, B. J.
    Fogarty, P. F.
    Pleil, A.
    Rubinstein, E.
    Alvir, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S111 - S111
12345